Vaccine therapy for malignant melanoma.
Morton
D L
DL
John Wayne Cancer Institute, Saint John's Hospital and Health Center, Santa Monica, California, USA.
Barth
A
A
D003131:Combined Modality Therapy; D006801:Humans; D016233:Immunotherapy, Active; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008545:Melanoma / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D011994:Recombinant Proteins; D012074:Remission Induction; D012878:Skin Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins